Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trojan, Jörg
CARP, NCT05551299: Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy	Recruiting	4	258	Europe	Photosensitizer, Photodynamic therapy (PDT), Radiofrequency ablation (RFA)	University of Leipzig, Zentrum für Klinische Studien Leipzig	Hilar Cholangiocarcinoma	04/28	04/28
CaboRISE, NCT04522908: Dose Escalation Study of Cabozantinib for Advanced HCC Patients with Preserved Liver Function	Completed	2	40	Europe	Cabozantinib Oral Tablet, CABOMETYX	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Johann Wolfgang Goethe University Hospital, Prof. Dr. med. Trojan	Hepatocellular Carcinoma (HCC), Second Line Treatment	10/24	10/24